Skip to main content
. 2022 Jan 5;8(1):e29872. doi: 10.2196/29872

Figure 1.

Figure 1

Self-reported localized reactions to COVID-19 vaccination among individuals with cancer, autoimmune diseases, or other serious comorbidities and/or their caregivers (n=5501 who received an initial vaccine dose; n=1390 who completed a 2-dose series).